-
Andexxa Blood Clot Lawsuits: Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Cases
Andexxa Lawsuits Filed Against Pharmaceutical Companies, Not Doctors Who Ordered Andexxa Posted by Tom Lamb at Drug Injury Watch) We have been investigating possible Andexxa blood clot lawsuits for the past two years. Pulmonary embolism (PE) and…
-
Vision Loss Associated With Ozempic, Mounjaro, And Other GLP-1 Drugs
People With Vision Loss Want Warnings Even If Risk Of NAION Eye Injury Is Low (Posted by Tom Lamb at Drug Injury Watch) For more than two years, we have seen numerous medical studies about vision loss…
-
NAION News Reports: GLP-1 Side Effect Harms Vision, Eyes
Ozempic, Wegovy, Mounjaro, Zepbound Associated With Loss of Eyesight (Posted by Tom Lamb at Drug Injury Watch) Non-arteritic anterior ischemic optic neuropathy (NAION) is a GLP-1 side effect that harms vision by causing damage to the eyes.…
-
Tavneos Liver Risks Confirmed by Medical Registry Data in the US
Possible Legal Compensation Cases for People Who Developed Tavneos Liver Injury (Posted by Tom Lamb at Drug Injury Watch) The FDA approved Tavneos (avacopan) in 2021 to treat anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV). We had been…
-
GLP-1 Lawsuits Involving NAION Filed in Federal Court: 200 Cases as of August 2026
Patients Using Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound Seek Legal Compensation for Vision Loss (Posted by Tom Lamb at Drug Injury Watch) In December 2025, GLP-1 lawsuits involving NAION filed in federal court were consolidated by the…
-
Ozempic Eye Problems Side Effect Warnings Not In US Drug Label
Ozempic NAION Risk Is Highlighted In Other Countries, So Why Not Here? (Posted by Tom Lamb at Drug Injury Watch) The current Prescribing Information document for Ozempic (Revised: 5/2026 version) in the US does not include any…
